Clinical trials
Respiratory Distress Syndrome trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 10 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
| Unknown status | 7 |
| Recruiting | 6 |
| Terminated | 2 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Istanbul University - Cerrahpasa | 5 |
| Başakşehir Çam & Sakura City Hospital | 4 |
| Dr. Behcet Uz Children's Hospital | 3 |
| Koç University | 3 |
| Zekai Tahir Burak Women's Health Research and Education Hospital | 3 |
| Hacettepe University | 2 |
| Ondokuz Mayıs University | 2 |
| Uludag University | 2 |
| Ankara Etlik City Hospital | 1 |
| Arch Biopartners Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Distress Syndrome | 47 |
| COVID-19 | 9 |
| Premature Birth | 7 |
| Pulmonary Atelectasis | 5 |
| Respiratory Insufficiency | 3 |
| Acute Lung Injury | 2 |
| Bronchopulmonary Dysplasia | 2 |
| Coronavirus Infections | 2 |
| Patient-Ventilator Asynchrony | 2 |
| Pneumonia | 2 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.